Provided by Tiger Trade Technology Pte. Ltd.

FibroBiologics

1.21
-0.0950-7.31%
Post-market: 1.260.0542+4.50%19:30 EDT
Volume:140.13K
Turnover:171.38K
Market Cap:8.02M
PE:-0.25
High:1.32
Open:1.32
Low:1.16
Close:1.30
52wk High:11.40
52wk Low:0.6201
Shares:6.66M
Float Shares:6.00M
Volume Ratio:0.81
T/O Rate:2.34%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.7656
EPS(LYR):-8.3501
ROE:-660.08%
ROA:-95.77%
PB:1.73
PE(LYR):-0.14

Loading ...

FibroBiologics announces grant of European patent

TIPRANKS
·
Sep 29

FibroBiologics Wins European Patent for Enhancing Fibroblast Therapeutic Activity

Reuters
·
Sep 29

FibroBiologics Shareholders Approve Potential Warrant-Driven Share Issuance

TIPRANKS
·
Sep 19

FibroBiologics Closes USD 0.5 Million Private Placement with Chief Scientific Officer

Reuters
·
Sep 17

Fibrobiologics Announces Closing of $0.5 Million Private Placement with Chief Scientific Officer

THOMSON REUTERS
·
Sep 17

Press Release: FibroBiologics Announces Closing of $0.5 Million Private Placement with Chief Scientific Officer

Dow Jones
·
Sep 17

Fibrobiologics Announces Issuance of New U.S. Patent for the Therapeutic Use of Fibroblasts in Wound Healing

THOMSON REUTERS
·
Sep 03

FibroBiologics Wins New US Patent Covering Topical Fibroblast-Based Wound Healing Therapy

Reuters
·
Sep 03

FibroBiologics Files Form 3 for Director Leigh Steinberg

Reuters
·
Sep 02

Fibrobiologics Announces Issuance of New U.S. Patent for the Treatment of Degenerative Disc Disease Using Fibroblast Conditioned Media

THOMSON REUTERS
·
Sep 01

FibroBiologics Ships Third Cywc628 Batch to Australia for Phase 1/2 Diabetic Foot Ulcer Trial

Reuters
·
Aug 27

Fibrobiologics Releases Third Batch of Cywc628 Drug Product for Phase 1/2 Diabetic Foot Ulcer Clinical Trial

THOMSON REUTERS
·
Aug 27

FibroBiologics Regains NASDAQ Compliance on $1 Minimum Bid-Price Rule

Reuters
·
Aug 26

Fibrobiologics Regains Compliance with NASDAQ Trading Rules

THOMSON REUTERS
·
Aug 26

FibroBiologics Appoints Sports Agent Leigh Steinberg to Board

Reuters
·
Aug 24

Fibrobiologics Appoints Leigh Steinberg to Board of Directors

THOMSON REUTERS
·
Aug 24

FibroBiologics Says Australia Accepts Patent Application for CBD Adjuvant Therapy in Degenerative Disc Disease

Reuters
·
Aug 20

Fibrobiologics Announces Australian Patent Accepted for Cannabidiol Adjuvant Therapy for the Treatment of Degenerative Disc Disease

THOMSON REUTERS
·
Aug 20

FibroBiologics announces laboratory findings in joint cartilage repair

TIPRANKS
·
Aug 18

FibroBiologics Says Chondrocyte Spheroids Repair Cartilage in Preclinical Degenerative Joint Study

Reuters
·
Aug 18